AMSTERDAM, April 20 (Reuters) - The European Union's drug
regulator said on Tuesday there had been more than 300 cases
worldwide of rare blood clotting incidents combined with low
platelet counts after use of COVID-19 vaccines.
There were 287 occurrences with the AstraZeneca vaccine,
eight with Johnson & Johnson's shot, 25 for Pfizer and five for
Moderna, said Peter Arlett, Head of Data Analytics at the
European Medicines Agency (EMA).
(Reporting by Anthony Deutsch and Toby Sterling
Editing by Gareth JOnes)
Astrazeneca (AZN)
